Doximity, Inc. (NASDAQ:DOCS) Director Sells $1,152,400.00 in Stock

Doximity, Inc. (NASDAQ:DOCS) Director Timothy S. Cabral sold 20,000 shares of Doximity stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $57.62, for a total value of $1,152,400.00. Following the sale, the director now directly owns 6,360 shares of the company’s stock, valued at $366,463.20. This trade represents a 75.87 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink.

Doximity Price Performance

Shares of Doximity stock opened at $58.14 on Thursday. The stock has a market capitalization of $10.85 billion, a P/E ratio of 66.82, a PEG ratio of 4.68 and a beta of 1.39. The business has a 50 day simple moving average of $54.98 and a two-hundred day simple moving average of $45.22. Doximity, Inc. has a 12 month low of $22.96 and a 12 month high of $61.75.

Doximity (NASDAQ:DOCS) last announced its quarterly earnings data on Thursday, November 7th. The company reported $0.24 earnings per share for the quarter, missing analysts’ consensus estimates of $0.26 by ($0.02). Doximity had a net margin of 33.69% and a return on equity of 19.79%. The firm had revenue of $136.83 million during the quarter, compared to analysts’ expectations of $127.05 million. During the same quarter in the previous year, the business posted $0.18 EPS. As a group, research analysts anticipate that Doximity, Inc. will post 0.88 EPS for the current fiscal year.

Analysts Set New Price Targets

DOCS has been the subject of several research reports. KeyCorp decreased their price objective on shares of Doximity from $70.00 to $65.00 and set an “overweight” rating for the company in a research note on Wednesday, January 8th. Canaccord Genuity Group downgraded shares of Doximity from a “buy” rating to a “hold” rating and boosted their target price for the company from $40.00 to $60.00 in a research report on Wednesday, November 13th. The Goldman Sachs Group assumed coverage on Doximity in a research note on Friday, November 15th. They issued a “neutral” rating and a $58.00 target price on the stock. Bank of America lifted their price target on Doximity from $54.00 to $57.00 and gave the company a “neutral” rating in a research report on Monday, January 6th. Finally, Barclays upped their price objective on Doximity from $52.00 to $75.00 and gave the stock an “overweight” rating in a research report on Monday, November 11th. Thirteen investment analysts have rated the stock with a hold rating, six have issued a buy rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average target price of $53.12.

Hedge Funds Weigh In On Doximity

Several hedge funds and other institutional investors have recently modified their holdings of DOCS. Handelsbanken Fonder AB grew its holdings in Doximity by 0.7% in the 4th quarter. Handelsbanken Fonder AB now owns 29,700 shares of the company’s stock valued at $1,586,000 after buying an additional 200 shares in the last quarter. UMB Bank n.a. boosted its position in shares of Doximity by 69.1% during the 4th quarter. UMB Bank n.a. now owns 575 shares of the company’s stock valued at $31,000 after acquiring an additional 235 shares during the last quarter. Fielder Capital Group LLC grew its holdings in shares of Doximity by 4.5% in the fourth quarter. Fielder Capital Group LLC now owns 5,488 shares of the company’s stock valued at $293,000 after purchasing an additional 235 shares during the period. GAMMA Investing LLC increased its position in Doximity by 20.6% during the fourth quarter. GAMMA Investing LLC now owns 1,735 shares of the company’s stock worth $93,000 after purchasing an additional 296 shares during the last quarter. Finally, MetLife Investment Management LLC raised its stake in Doximity by 0.6% during the third quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock worth $2,835,000 after purchasing an additional 363 shares during the period. 87.19% of the stock is owned by hedge funds and other institutional investors.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.